Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2 and removed older dates from April 2025 and December 2024. The new version includes more recent dates, indicating a refresh of content.SummaryDifference0.3%
- Check16 days agoChange DetectedThe webpage has added new dates for the biopsy procedure, specifically April 15 and April 16, 2025, while removing previous dates from early February 2025.SummaryDifference0.4%
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial involving cabozantinib and nivolumab for treating advanced endometrial cancer, while adding new identifiers and procedural information related to the trial.SummaryDifference54%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 5, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 5, 2025, and version 2.14.2.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.